sacituzumab govitecan
gilead sciences
['bcsm', 'sacituzumab govitecan', 'breast']
sacituzumab govitecan demonstrates significant clinical benefit in hr+/her2- metastatic breast cancer #asco22 #bcsm
SVP, Content @MJHLifeSciences. Focused on creating innovative, expert-driven content @OncLive @MedEconomics @AJMC_Journal @Pharmacy_Times @MDMagazine plus more